These medications mimic gut hormones to reduce appetite, slow gastric emptying, and improve blood sugar control. They deliver real benefits for people with obesity or type 2 diabetes, but they’re not the miracle “easy button” portrayed in some media or celebrity endorsements. Here’s a breakdown of common exaggerations, myths, and realities.
Real Effectiveness (Not a Lie)
Clinical trials show semaglutide can lead to average weight loss of 15% or more of body weight over 1+ years when combined with diet and exercise—far better than many older options. Some achieve 20%+ loss. It also offers cardiovascular benefits, lowers blood pressure in some cases, and improves metabolic markers.
This is substantial for obesity-related health risks. However, results vary widely—some people lose little, and it’s not “guaranteed” success.
Major Myths and Exaggerations (“Lies”)
- “You’ll keep the weight off forever” or “It’s a permanent fix”:
False. These drugs require ongoing use for most people to maintain results. Studies show people often regain about two-thirds of lost weight within a year of stopping, as appetite signals return. Net loss may persist modestly with strong lifestyle habits, but rebound is common. Long-term use (potentially lifelong) is the realistic path for sustained effects. - “No downside—just take it and slim down”:
Side effects are frequent, especially gastrointestinal: nausea, vomiting, diarrhea, constipation, abdominal pain. These often improve but can be severe or persistent for some (e.g., gastroparesis or bowel issues in rarer cases). Other concerns include fatigue, “Ozempic face” (sagging skin from rapid loss), potential muscle/lean mass loss, and rare risks like pancreatitis, gallbladder problems, kidney issues, or vision changes. Rodent studies raised thyroid tumor flags (boxed warning), though human links remain unclear. - “It melts fat, not muscle”:
Oversold. Rapid weight loss from any cause (including these drugs) includes some lean mass loss alongside fat. Strength training and adequate protein are crucial to mitigate this. - “It’s just a vanity drug” or “cheating”:
This is moralizing, not science. For people with clinical obesity, these drugs address a chronic condition with real health impacts (heart disease, diabetes, etc.). Lifestyle changes remain foundational—meds aren’t a substitute for diet/exercise, and labels emphasize combining them. - “Totally safe long-term with no unknowns”:
Data is still maturing. Four-year studies (e.g., SELECT trial) show sustained benefits and generally good safety for many, with fewer serious adverse events than placebo in some metrics. But widespread use is recent, and questions remain about very long-term effects, optimal duration, and risks in broader populations. Counterfeits add dangers. - “Works the same for everyone / anyone can/should use it”:
No. It’s most appropriate for those with BMI ≥30 (or ≥27 with comorbidities). Not everyone responds equally, and it’s not a casual diet aid.
The Craze Context
Shortages, high costs, off-label prescribing, and social media have amplified the hype. It’s a powerful tool but not risk-free or effortless. Muscle preservation, nutrition, and exercise matter more than ever during use. For many, the benefits (especially for those with obesity-related conditions) outweigh risks under medical supervision—but it’s no substitute for addressing root causes like food environment, habits, and genetics.
Consult a doctor for personalized advice. These drugs represent real medical progress, but the craze often ignores trade-offs, sustainability, and the need for holistic approaches.
About The Author
